These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 37506675)

  • 21. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Przybylski DJ; Reeves DJ
    Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.
    Monti M; Silimbani P; Ruscelli S; Frassineti GL
    Expert Opin Drug Saf; 2020 Aug; 19(8):1055-1056. PubMed ID: 32427001
    [No Abstract]   [Full Text] [Related]  

  • 23. Appropriate use of fluoroquinolones in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.
    Paterson JM; Mamdani MM; Manno M; Juurlink DN;
    CMAJ; 2012 Oct; 184(14):1565-70. PubMed ID: 22891208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.
    Lee J; Lee CH; Kim DK; Yoon HI; Kim JY; Lee SM; Yang SC; Lee JH; Yoo CG; Lee CT; Chung HS; Kim YW; Han SK; Yim JJ
    Korean J Intern Med; 2011 Jun; 26(2):153-9. PubMed ID: 21716591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
    Al-Shaer MH; Alghamdi WA; Alsultan A; An G; Ahmed S; Alkabab Y; Banu S; Barbakadze K; Houpt E; Kipiani M; Mikiashvili L; Cegielski JP; Kempker RR; Heysell SK; Peloquin CA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
    Mather R; Karenchak LM; Romanowski EG; Kowalski RP
    Am J Ophthalmol; 2002 Apr; 133(4):463-6. PubMed ID: 11931779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.
    Kuo SC; Chen YT; Lee YT; Fan NW; Chen SJ; Li SY; Liu CJ; Chen TL; Chen TJ; Fung CP
    Clin Infect Dis; 2014 Jan; 58(2):197-203. PubMed ID: 24170197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis.
    DE Nunzio C; Nacchia A; Lombardo R; Franco A; Cicione A; Trucchi A; Labella M; Bartoletti R; Simonato A; Ficarra V; Tubaro A
    Minerva Urol Nephrol; 2023 Jun; 75(3):374-380. PubMed ID: 36940165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
    Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
    J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
    Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
    J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
    Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
    Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis.
    Liu X; Ma J; Huang L; Zhu W; Yuan P; Wan R; Hong K
    Medicine (Baltimore); 2017 Nov; 96(44):e8273. PubMed ID: 29095256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysis.
    Aspinall SL; Sylvain NP; Zhao X; Zhang R; Dong D; Echevarria K; Glassman PA; Goetz MB; Miller DR; Cunningham FE
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00664. PubMed ID: 33047487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk for uveitis with oral moxifloxacin: a comparative safety study.
    Eadie B; Etminan M; Mikelberg FS
    JAMA Ophthalmol; 2015 Jan; 133(1):81-4. PubMed ID: 25275293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.
    Morganroth J; Dimarco JP; Anzueto A; Niederman MS; Choudhri S;
    Chest; 2005 Nov; 128(5):3398-406. PubMed ID: 16304291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers.
    Lubasch A; Keller I; Borner K; Koeppe P; Lode H
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2600-3. PubMed ID: 10991830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.